Product Details: Number of Reactions(Preps)/Kit ; 2 Brand ; Genbody Test Method : Antigen Test Result Time (Rapid Kits) : 10-15 mins Certified : CE certified Cat. No : COVAG025-1 The GenBody COVID-19 Ag is an immunochromatographic rapid diagnostic test (RDT) intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) oranteriornasal (AN) swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first six days of symptom onset
Cat No : RK081-25. Ulta Covid-19 Ag test is a rapid Immunochromatographic assey for the qualitative detection of specific antigens to SAR-COV-2 present in human nasopharynx.
CAT No : RK055-25. STANDARD Q COVID-19 Ag is a rapid Immunochromatographic assay for the qualitative detection of specific antigens to SARS-CoV-2 present in human nasopharynx. Qualitatively detects specific antigens to SARS-CoV-2 present in Human Nasopharynx. The test should be used as an aid in early diagnosis of symptomatic cases in healthcare setting having ILI. Validated by ICMR & AIIMS Sensitivity of 84.38 % & Specificity of 100% Sample Type- Human Nasopharyngeal swab (No other sample recommended) Results in 15-30 mins
ImmunoQuick Covid-19 IgM/IgG Test : Covid-19 or commonly known as Coronavirus is a viral infection involving a patients upper respiratory tract. It is highly contagious and causes a severe lung infection which can be severely debilitating and sometimes fatal. Our test detects two types of antibodies to Covid-19 which appear from 2 to 21 days after infection. It is an invaluable test to diagnose people who have been sick for a few days or those who have recovered. Salient Features of the Product It is rapid immunoassay for qualitative detection of Covid-19 IgM and IgG antibodiesin Human Serum or Plasma or Whole Blood. Results available in 15 minutes. Sensitivity :: >96% Specificity :: >99% No cross reactivity observed. Can be stored at 4 to 30C Stable for 24 months. Pack size :: 25 tests.
CAT No : 41FK51. The Panbio COVID-19 Antigen Self-Test is a single-use, in vitro (outside the body) visually read rapid immunoassay that uses a human nasal swab specimen for the qualitative detection of nucleocapsid protein SARS-CoV-2 antigen. The test can determine if you have an active COVID-19 infection and you will know your test results in just 15 minutes Only Proven High-Accuracy Self-Test in India In clinical evaluations with self-test users, the Panbio COVID-19 Antigen Self-Test correctly identified 100% of negative samples and 95.2% of Positive Samples Pregnancy had no impact on the performance of the test.
Genbody Influenza/ Covid - 19 Ag Triple, Rapid immuno-diagnosis of influenza A, B & SARS-CoV Single test for 3 parameters: antigen test of influenza A,B & SARS-CoV-2 Easy to use, Simple Procedure, Quick resulting and high Accuracy. Production information: 1.Specimen: nasopharyngeal swab or Viral transport medium (VTM) 2.No Cross-reaction with 27 kinds of other respiratory viruses. 3.No interference with 23 kinds of interfering substances. 4.Limit of detection (LoD):1.89x10 HA units/mL for influenza A, 4.1 x 10 HA units/ mL for influenza B, 1.78x10 TCID/mL for SARS-CoV-2. 5.Detection of SARS-CoV-2 Varients: alpha,beta,gamma, delta, omicron & stealth omicron.
- EXW $8.5 (in USA)/test (2 test kits/1 inbox) - Non-Prescription Home Test Kit (Individual Use). - Result in 15 min. - FDA (EUA), CE approved. - Supply from authorized Distributor in the USA - Gaurantee that our price is cheaper than other suppliers - Celltrion supplies their antigen to the US Department of Defense -> PROVED QUALITY
Quantity: 250,000 (250K) Lyher - 1 tests per package - price ¬ 1.70 officially approved by the BfArM test suitable for lay use rapid sampling through the nose user-friendly step-by-step instructions Test result within 15 minutes LYHER Novel Coronavirus (COVID-19) Antigen Test Kit (Colloidal Gold) from the manufacturer Hangzhou Laihe Biotech Co., Ltd., China If interested, just let us know Quantity: 250.000 (250K) Lyher â?? 1 tests per package â?? Preis â?¬1,70 offiziell durch das BfArM zugelassener Test geeignet f�¼r Laienanwendungen schnelle Probenentnahme durch die Nase benutzerfreundliche Schritt-f�¼r-Schritt-Anleitung Testergebnis innerhalb von 15 Minuten LYHER Novel Coronavirus (COVID-19) Antigen Test Kit (Colloidal Gold) des Herstellers Hangzhou Laihe Biotech Co., Ltd., China
1.7 Mill pieces LEPU - Covid quick test 1,04 USD ;0.88,- Euro ; OTG Eu
SARS-CoV-2 Test Kit made in Korea: - Target Gene: Orf-1ab gene & E-gene - Performance: Sensitivity: 77 genome copy equivalents/rxn - Running time:
[ZENITH GROUP] COVID-19 Test Kit o Product Name - PCL COVID-19 AG Test Kit(Salvia) - PCL COVID-19 lgG/lgM o Price (USD) : 3.2$ (FOB) - Can be discussed up to order Qty - 10,000 : 3.2$ - 100,000 : 3.0$ - 1,000,000 : 2.8$ o MOQ : 10,000 pcs o Payment : 100% L/C at sight, irrevocable, transferable LC o Delivery Time- Up to Qty- Capacity : 3,000,000pcs / 1week
This device is a qualitative serology test based on immunochromatography. The appearance of a coloured band indicates the presence of the antibody within 10 minutes. The test can be used for vaccination control. This test controls two types of antibodies in parallel: IgM and IgG. The IgM antibody level starts to be truly detectable about a week after the initial infection, while IgG usually appears within 14 days of infection and can last for several months or even years. The device is now approved by the Ministry of Health. Using two drops of blood, the test can detect COVID-19 in less than 10 minutes. The test is based on the detection of antibodies specific to the disease. The test has the advantage of giving a result during and after contamination. The specificity of the test (IgM and IgG) is 100% (study carried out by different hospitals). The sensitivity of the test is 92.8% for IgM antibodies and 96.5% for IgG antibodies for false negatives (1300 tests). The performance values of our device are in line with the recommendations of the Haute Autorit de Sant (HAS) The test have been approved and controlled by French government (ANR: Pasteur)
covid tests
PRICE PER TEST $8.99 TEST BinaxNOW COVID-19 Ag Card For Rapid Detection of SARS-CoV-2 | FDA EUA | IVD Use | RX Only The BinaxNOW COVID-19 Ag Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset. Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in anterior nasal (nares) swabs during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Negative results should be treated as presumptive, do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. The BinaxNOW COVID-19 Ag Card is intended for use by medical professionals or trained operators who are proficient in performing rapid lateral flow tests. BinaxNOW COVID-19 Ag Card is only for use under the Food and Drug Administration's EUA. Kit Details Test Card: 40 cards with test strips Extraction Reagent: bottle containing 7.5 mL of extraction reagent Nasal swabs: 40 sterile, single use specimen sampling swabs Positive Control Swab: 1 each â??individually wrapped for single use Negative Control Swab: 1 each â??individually wrapped for single use Documentation: Product Insert, Procedure Card Performance Data Sensitivity: 97.1% Specificity: 98.5%
US FDA approved test kit 93.3% sensitivity in confirming COVID-19 cases. Nasopharyngeal test We have OTG and production deals
We are a manufacturer of SARS-CoV2 (Covie-19) antigen RAPID TEST CASSETTE. The Genesea SARS-CoV-2 Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection the antigen from SARS-CoV-2 in nasal swab, nasopharyngeal swab, oropharyngeal swab specimens. The products have CE certification, We can provide you at cheapst price. Delivery time 5days. Capacity 10million tests/month
DEAR, LIVE STOCK BELGIUM MOQ : 500 PRICE : 2,5â?¬/ TEST + delivery cost 1 pack First come, First served
Covid antigen rapid test kit made in Turkey seller : manufactory company minimum order : 10,000 pcs Licensed in Europe and UK 1 box 25 pcs T/T
[Intended Usage] This kit is used for the in vitro qualitative detection of suspected cases of pneumonia caused by New Coronavirus infection, patients with suspected clusters, other patients who need to be diagnosed or differentially diagnosed with the New Coronavirus infection, and nasopharyngeal swabs, oropharyngeal swabs, and bronchoalveolar lavage fluid samples of patients with mutation beads for the New Coronavirus ORF1ab and N gene, S gene N501Y mutation and S gene E484K mutation sites. [Storage Conditions & Validity] 1. The kit should be stored frozen at -20 and protected from light; the expiration date is 6 months; the production date and expiration date are shown in the outer packaging box. 2. Avoid repeated freezing and thawing of the kit and the number of freezing and thawing shall not exceed 7 times. 3. After opening, the bottles should be stored at -20 and protected from light. The number of bottles opening times should not exceed 7 times, which will not affect the use within the validity period. [Applicable Instruments] 1. This kit has been validated on ABI7500 quantitative fluorescence PCR instrument. 2. For other models not listed, relevant experiments have not been performed or completed for this kit. If users need to use this type of instrument platform to carry out the detection of this reagent, please contact our Technical Department at for relevant support. NB: The other devices can include quantitative fluorescence PCR platforms with FAM, VIC, ROX and Cy5 channels. [Sample Requirements] 1. Nasopharyngeal swabs, oropharyngeal swabs and other methods are used to obtain samples, and it is recommended to use commercial virus sampling kits for sample collection devices. [Test Results Interpretation] 1. Negative and positive controls should be tested in each experiment and the test result can be determined only when the controls meet the quality control requirements. 2. When FAM, VIC and ROX channels are positive, Cy5 channel result may be negative due to the system competition. 3. When the internal standard result is negative, if the FAM, VIC and ROX signals of the test sample are also negative, the test result of the sample is invalid, and the cause should be found and eliminated, and the experiment repeated for this sample. [Product Performance Index] 1. Precision: The coefficient of variation Intra-batch / Inter-batch, Intra-day / Inter-day among different operators shall not be higher than 5.0%. 2. Coincidence rate of negative positive controls: The coincidence rate of positive controls and negative controls is 100%. 3. Minimum detection limit: The minimum detection limit of this kit is 500 copies/mL. [CE Mark Registration No.]: RPS/499/2021. [EC REP.]: CMC MEDICAL DEVICES & DRUGS S.L. C/ Horacio Lengo n18, C.P 29006, Milaga, Spain.
INTENDED USE For qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in serum, plasma (EDTA, sodium citrate and lithium heparin) or fingerstick whole blood, venous whole blood specimens from patients suspected of COVID-19 infection. FEATURES Coated with carefully selected specific Nucleocapsid and Spike protein antigen. Detection for IgM and IgG antibodies simultaneously. Simple operation, easy result interpreted. Rapid test within 15 minutes. RESULTS INTERPRETATION Positive: 1. The presence of 3 red lines (T1, T2 and C) within the reaction window, no matter which band appears first, indicates presence of both SARS-CoV-2 IgM and IgG antibodies. 2. The presence of 2 red lines (T1 and C) within the reaction window, no matter which band appears first, indicates presence of SARS-CoV-2 IgM antibody. 3. The presence of 2 red lines (T2 and C) within the reaction window, no matter which band appears first, indicates presence of SARS-CoV-2 IgG antibody. Negative: 1. The presence of line (control line) only within the reaction window indicates that no SARS-CoV-2 antibodies are detected. The results is negative. Invalid: 1. If the control(C) line is not displayed in 10-15 min, regardless of whether T1 and/or T2 line is present, the test result is invalid. It is recommended that the specimen should be re-tested. 2. The test result is invalid after 15 min. CLINICAL PERFORMANCE - Positive Percent Agreement (PPA) = 91.07% (153/168) (95% CI: 85.70%-94.92%). - Negative Percent Agreement (NPA) = 95.37% (103/108) (95% CI: 89.53%-98.48%). - Overall Rates of Agreement (ORA) = 92.75% [(153+103)/ (168+108)] (95% CI: 89.03%-95.52%). [Product Name]: SARS-CoV-2 IgM/IgG Duo Test [Product Code]: Cat# FP-319 [Sample Type]: Whole blood /Plasma/Serum [Sample Volume]: 20L /10L/10L [Detection Method]: Colloidal Gold [Reaction Time]: 10-15min [Packing Size]: 1T x 20 cassettes per box + Sample diluent 1 vial x 5mL. [Storage Condition]: 2oC ~ 30oC [Shelf Life]: 12 months [CE Mark Registration No.]: RPS/499/2021.
